알츠하이머병에서 망상

키워드

참고문헌 (87)

1. Steinberg M, "Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study", Int J Geriatr Psychiatry, 23, pp.170~177 (2008)
2. Wiener PK, "A short-term inpatient program for agitated demented nursing home residents", Int J Geriatr Psychiatry, 16, pp.866~872 (2001)
3. Murray R, "The essentials of postgraduate psychiatr", pp.231~ (1997), Cambridge University Press
4. Alzheimer A, "Uber eine eigenartige rkrankung der hirnrinde", Allg Z Psychiat Psych Gerichtl Med, 64, pp.146~148 (1907)
5. Fischer C, "Review of delusions in dementia", Am J Alzheimer’s Dis Other Dements, 19, pp.19~23 (2004)
6. Holt AE, "Cognitive neuroscience of delusions in aging", Neuropsychiatr Dis Treat, 2, pp.181~189 (2006)
7. Levy ML, "Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer’s disease", Am J Psychiatry, 153, pp.1438~1443 (1996)
8. Gilley DW, "Psychotic symptoms and physically aggressive behavior in Alzheimer’s disease", J Am Geriatr Soc, 45, pp.1074~1079 (1997)
9. Gormley N, "Clinical predictors of aggressive behaviour in Alzheimer’s disease", Int J Geriatr Psychiatry, 13, pp.109~115 (1998)
10. Haupt M, "Delusions and hallucinations in Alzheimer’s disease : results from a two year longitudinal study", Int J Geriatr Psychiatry, 11, pp.965~972 (1996)
11. Rabins PV, "The impact of dementia on the family", JAMA, 248, pp.333~335 (1982)
12. Steele C, "Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease", Am J Psychiatry, 147, pp.1049~1051 (1990)
13. Haupt M, "Predictors of nursing home placement in patients with-Alzheimer’s disease", Int J Geriatr Psychiatry, 8, pp.741~746 (1993)
14. Jeste DV, "Psychosis of Alzheimer’s disease and related dementias. Diagnostic criteria for a distinct syndrome", Am J Geriatr Psychiatry, 8, pp.29~34 (2000)
15. Lyketsos CG, "An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer’s disease", Int J Geriatr Psychiatry, 16, pp.1037~1042 (2001)
16. Mizrahi R, "Phenomenology and clinical correlates of delusions in Alzheimer disease", Am J Geriatr Psychiatry, 14, pp.573~581 (2006)
17. Jeste DV, "Cognitive deficits of patients with Alzheimer’s disease with and without delusions", Am J Psychiatry, 149, pp.184~189 (1992)
18. Migliorelli R, "Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer’s disease", Psychol Med, 25, pp.505~513 (1995)
19. Ikeda M, "Delusions of Japanese patients with Alzheimer’s disease", Int J Geriatr Psychiatry, 18, pp.527~532 (2003)
20. Bassiony MM, "Delusions and hallucinations in Alzheimer’s disease : prevalence and clinical correlates", Int J Geriatr Psychiatry, 15, pp.99~107 (2000)
21. Ropacki SA, "Epidemiology of and risk factors for psychosis of Alzheimer’s disease: a review of 55 studies published from 1990 to 2003", Am J Psychiatry, 162, pp.2022~2030 (2005)
22. Weamer EA, "The relationship of excess cognitive impairment in MCI and early Alzheimer’s disease to the subsequent emergence of psychosis", Int psychogeriatrics, 21, pp.78~85 (2009)
23. Ostling S, "Psychotic Symptoms in a Population-Based Sample of 85-Year-Old Individuals With Dementia", J Geriatr Psychiatry Neurol, 24, pp.3~8 (2011)
24. Sweet RA, "Assessment and familial aggregation of psychosis in Alzheimer’s disease from the National Institute on Aging Late Onset Alzheimer’s Disease Family Study", Brain, 133, pp.1155~1162 (2010)
25. Harciarek M, "The prevalence of misidentification syndromes in neurodegenerative diseases", Alzheimer disease and associated disorders, 22, pp.163~169 (2008)
26. Savva GM, "Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population", Br J Psychiatry, 194, pp.212~219 (2009)
27. Kwak YT, "Delusions of Korean patients with Alzheimer’s disease : study of drug-naïve patients", Geriatr Gerontol Int, 13, pp.307~313 (2013)
28. Paulsen JS, "Incidence of and risk factors for hallucinations and delusions in patients with probable AD", Neurology, 54, pp.1965~1971 (2000)
29. Caligiuri MP, "Neuromotor abnormalities and risk for psychosis in Alzheimer’s disease", Neurology, 61, pp.954~958 (2003)
30. Ballard CG, "The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer’s disease : persistence and new cases over 1 year of follow-up", J Clin Psychiatry, 62, pp.46~49 (2001)
31. Devanand DP, "The course of psychopathologic features in mild to moderate Alzheimer disease", Arch Gen Psychiatry, 54, pp.257~263 (1997)
32. Davidson M, "Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients with Alzheimer’s disease", Am J Psychiatry, 153, pp.1274~1279 (1996)
33. Jeste DV, "Conventional antipsychotics in elderly patients", Am J Geriatr Psychiatry, 7, pp.70~76 (1999)
34. Marin DB, "Noncognitive disturbances in Alzheimer’s disease: frequency, longitudinal course, and relationship to cognitive symptoms", J Am Geriatr Soc, 45, pp.1331~1338 (1997)
35. Tariot PN, "The behavior rating scale for dementia of the consortium to establish a registry for Alzheimer’s disease", Am J Psychiatry, 152, pp.1349~1357 (1995)
36. Rubin EH, "Nature of psychotic symptoms in senile dementia of the Alzheimer type", J Geriatr Psychiatry Neurol, 1, pp.17~20 (1988)
37. Schneider LS, "Psychosis of Alzheimer disease : validity of the construct and response to risperidone", Am J Geriatr Psychiatry, 11, pp.414~425 (2003)
38. Forstl H, "Neuropathological correlates of psychotic phenomena in confirmed Alzheimer’s disease", Br J Psychiatry, 165, pp.53~59 (1994)
39. Nagata T, "Correlation between a reduction in Frontal Assessment Battery scores and delusional thoughts in patients with Alzheimer’s disease", Psychiatry Clin Neurosci, 63, pp.449~454 (2009)
40. Perez-Madrinan G, "Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype", Am J Geriatr Psychiatry, 12, pp.449~456 (2004)
41. Forstl H, "Delusional misidentification in Alzheimer’s disease : a summary of clinical and biological aspects", Psychopathology, 27, pp.194~199 (1994)
42. Kwak YT, "The Neuropsychological Characteristics of Misidentification Syndrome", J Neurol Transl Neurosci, 1, pp.1015~ (2013)
43. Aron AR, "Stop signal inhibition disrupted by damage to right inferior frontal gyrus in humans", Nat Neurosci, 6, pp.115~116 (2003)
44. Chambers CD, "Executive"brake failure"following deactivation of human frontal lobe", J Cogn Neurosci, 18, pp.444~455 (2006)
45. Buchsbaum BR, "Meta-analysis of neuroimaging studies of the Wisconsin card-sorting task and component processes", Hum Brain Mapp, 25, pp.35~45 (2005)
46. Chikazoe J, "Activation of right inferior frontal gyrus during response inhibition across response modalities", J Cogn Neurosci, 19, pp.69~80 (2007)
47. Cook SE, "Psychotic symptoms in Alzheimer disease : evidence for subtypes", Am J Geriatr Psychiatry, 11, pp.406~413 (2003)
48. Chemerinski E, "Prevalence and correlates of aggressive behavior in Alzheimer’s disease", J Neuropsychiatry Clin Neurosci, 10, pp.421~425 (1998)
49. Lam LC, "Behavioral profile of Alzheimer’s disease in Chinese elderly – a validation study of the Chinese version of the Alzheimer’s disease behavioral pathology rating scale", J Geriatr Psychiatry, 16, pp.368~373 (2001)
50. 곽용태, "Clinical Characteristics of Behavioral and Psychological Symptoms in Patients with Drug-naïve Alzheimer’s Disease", Dementia and Neurocognitive Disorders(대한치매학회지), 11(3), pp.87~94 (2012), 대한치매학회
51. Zubenko GS, "Neuropathologic and neurochemical correlates of psychosis in primary dementia", Arch Neurol, 48, pp.619~624 (1991)
52. Mukaetova-Ladinska EB, "Treating Alzheimer’s and other dementias", pp.57~80 (1995), Springer
53. Farber NB, "Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis", Arch Gen Psychiatry, 57, pp.1165~1173 (2000)
54. Lai MK, "Psychosis of Alzheimer’s disease is associated with elevated muscarinic M2 binding in the cortex", Neurology, 57, pp.805~811 (2001)
55. Sweet RA, "Psychosis in Alzheimer disease : postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology", Neurobiol Aging, 23, pp.547~553 (2002)
56. Cohen-Mansfield J, "The meanings of delusions in dementia: a preliminary study", Psychiatry Res, 189, pp.97~104 (2011)
57. Sultzer DL, "Delusional thoughts and regional frontal", temporal cortex metabolism in Alzheimer’s disease, 2003, pp.160, 341~349
58. Starkstein SE, "A SPECT study of delusions in Alzheimer’s disease", Neurology, 44, pp.2055~2059 (1994)
59. Kotrla KJ, "SPECT findings on psychosis in Alzheimer’s disease", Am J Psychiatry, 152, pp.1470~1475 (1995)
60. Geroldi C, "Temporal lobe asymmetry in patients with Alzheimer’s disease with delusions", J Neurol Neurosurg Psychiatry, 69, pp.187~191 (2000)
61. Matsuoka T, "Insular hypoperfusion correlates with the severity of delusions in individuals with Alzheimer’s disease", Dement Geriatr Cogn Disord, 29, pp.287~293 (2010)
62. Ismail Z, "Neuroimaging of delusions in Alzheimer’s disease", Psychiat, 202, pp.89~95 (2012)
63. Tunstall N, "Familial influence on variation in age of onset and behavioural phenotype in Alzheimer’s disease", Br J Psychiatry, 176, pp.156~159 (2000)
64. Avramopoulos D, "Linkage to chromosome 14q in Alzheimer’s disease(AD)patients without psychotic symptoms", Am J Med Genet B Neuropsychiatr Genet, 132, pp.9~13 (2005)
65. Scarmeas N, "Association between the APOE genotype and psychopathologic symptoms in Alzheimer’s disease", Neurology, 58, pp.1182~1188 (2002)
66. Spalletta G, "Delusion symptoms are associated with ApoE epsilon4 allelic variant at the early stage of Alzheimer’s disease with late onset", Eur J Neurol, 13, pp.176~182 (2006)
67. Pritchard AL, "The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer’s disease", J Neurol Neurosurg Psychiatry, 78, pp.123~126 (2007)
68. Borroni B, "Genetic correlates of behavioral endophenotypes in Alzheimer disease:role of COMT, 5-HTTLPR and APOE polymorphisms", urobiol Aging, 27, pp.1595~1603 (2006)
69. Assal F, "Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease", Arch Neurol, 61, pp.1249~1253 (2004)
70. Angelucci F, "Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism(102 T", C)in Alzheimer’s disease : a 3-year follow-up longitudinal study, 2009, pp.17, 203~211
71. Holmes C, "Psychosis and aggression in Alzheimer’s disease : the effect of dopamine receptor gene variation", J Neurol Neurosurg Psychiatry, 71, pp.777~779 (2001)
72. Cipriani G, "Aggressive behavior in patients with dementia: correlates and management", Geriatr Gerontol Int, 11, pp.408~413 (2011)
73. Cantley C, "A Handbook of Dementia Care" (2001), Open University
74. Ayalon L, "Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review", Arch Intern Med, 166, pp.2182~2188 (2006)
75. Alexopoulos GS, "The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary", Postgrad Med, pp.6~22 (2005)
76. Schneider LS, "Risk of death with atypical antipsychotic drug treatment for dementia : metaanalysis of randomized placebo-controlled trials", JAMA, 294, pp.1934~1943 (2005)
77. Yaffe K, "Treatment of neuropsychiatric symptoms in patients with dementia", N Engl J Med, 357, pp.1441~1443 (2007)
78. Karim S, "Treatment of psychosis in elderly people", Adv Psychiatr Treat, 11, pp.286~296 (2005)
79. Holmes C, "The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease", Neurology, 63, pp.214~219 (2004)
80. 윤진상, "알쯔하이머병 환자의 행동심리적 증상에 대한 Donepezil의 효과", 대한정신약물학회지, 14(2), pp.129~137 (2003), 대한정신약물학회
81. Paleacu D, "Donepezil for the treatment of behavioral symptoms in patients with Alzheimer’s disease", Clin Neuropharmacol, 25, pp.313~317 (2002)
82. Barak Y, "Donepezil for the treatment of behavioral disturbances in Alzheimer’s disease : A 6-month open trial", Arch Gerontol Geriatr, 33, pp.237~241 (2001)
83. Cummings JL, "Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer’s disease:a 26-week, multicenter, open-label study", Am J Geriatr Pharmacother, 3, pp.137~148 (2005)
84. Rosler M, "Efficacy and safety of rivastigmine in patients with Alzheimer’s disease : International randomised controlled trial", BMJ, 318, pp.633~638 (1999)
85. Cummings JL, "Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer’s disease", Am J Psychiatry, 161, pp.532~538 (2004)
86. Sasaki S, "The Effects of an Uninterrupted Switch from Donepezil to Galantamine without Dose Titration on Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease", Dement Geriatr Cogn Dis Extra, 21, pp.131~139 (2014)
87. Pollock BG, "A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia", Am J Geriatr Psychiatry, 15, pp.942~952 (2007)

관련 논문AI추천